HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow-to-Debt Ratio
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of CN¥-187.38 Million could theoretically repay 0% of its total liabilities (CN¥4.03 Billion) in one year. See 600829 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. Also explore 600829 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year debt coverage analysis for HPGC Renmintongtai Pharmaceutical Corp. For market capitalisation and broader financial context, see market cap of HPGC Renmintongtai Pharmaceutical Corp.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥299.98 Million | CN¥4.16 Billion | ▲ +167.7% |
| 2024 | 0.03x | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.07x | CN¥332.99 Million | CN¥4.68 Billion | ▲ +6.5% |
| 2022 | 0.07x | CN¥307.33 Million | CN¥4.60 Billion | ▲ +230.5% |
| 2021 | -0.05x | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -2123.4% |
| 2020 | 0.00x | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +97.9% |
| 2019 | -0.11x | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -186.0% |
| 2018 | 0.13x | CN¥366.45 Million | CN¥2.83 Billion | ▲ +200.4% |
| 2017 | 0.04x | CN¥139.07 Million | CN¥3.23 Billion | ▲ +196.0% |
| 2016 | 0.01x | CN¥46.01 Million | CN¥3.16 Billion | ▼ -87.8% |
| 2015 | 0.12x | CN¥333.99 Million | CN¥2.81 Billion | ▼ -65.8% |
| 2014 | 0.35x | CN¥392.58 Million | CN¥1.13 Billion | ▲ +417.2% |
| 2013 | -0.11x | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -186.4% |
| 2012 | 0.13x | CN¥221.57 Million | CN¥1.75 Billion | ▲ +323.6% |
| 2011 | -0.06x | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -155.1% |
| 2010 | 0.10x | CN¥162.99 Million | CN¥1.58 Billion | ▼ -72.5% |
| 2009 | 0.37x | CN¥447.82 Million | CN¥1.20 Billion | ▲ +818.3% |
| 2008 | -0.05x | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -134.7% |
| 2007 | 0.15x | CN¥191.10 Million | CN¥1.27 Billion | ▼ -9.3% |
| 2006 | 0.17x | CN¥191.13 Million | CN¥1.16 Billion | ▼ -41.9% |
| 2005 | 0.28x | CN¥313.04 Million | CN¥1.10 Billion | ▲ +288.0% |
| 2004 | 0.07x | CN¥60.69 Million | CN¥828.09 Million | ▼ -47.2% |
| 2003 | 0.14x | CN¥71.65 Million | CN¥516.46 Million | ▼ -56.1% |
| 2002 | 0.32x | CN¥127.49 Million | CN¥403.72 Million | ▲ +881.2% |
| 2001 | 0.03x | CN¥14.79 Million | CN¥459.59 Million | ▼ -72.2% |
| 2000 | 0.12x | CN¥61.85 Million | CN¥534.74 Million | ▼ -42.9% |
| 1999 | 0.20x | CN¥58.21 Million | CN¥287.56 Million | ▲ +19.4% |
| 1998 | 0.17x | CN¥41.00 Million | CN¥241.76 Million | — |